Haemonetics HAE Blood Center — Cost of goods sold
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's blood center — cost of goods sold.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's blood center — cost of goods sold?
- Haemonetics (HAE) reported blood center — cost of goods sold of $30.67M in Q1 2026.
- How has Haemonetics's blood center — cost of goods sold changed year-over-year?
- Haemonetics's blood center — cost of goods sold increased by 3.0% year-over-year, from $29.79M to $30.67M.
- What is the long-term trend for Haemonetics's blood center — cost of goods sold?
- Over 3 years (2023 to 2026), Haemonetics's blood center — cost of goods sold has grown at a -7.9% compound annual growth rate (CAGR), from $144.36M to $112.67M.
- What does blood center — cost of goods sold mean?
- Represents the direct costs attributable to the production of goods and services sold within the Blood Center segment. This includes raw materials, direct labor, and manufacturing overheads required to deliver blood collection and processing solutions. Monitoring this metric helps assess the direct production efficiency and cost management of the segment.